Lidocaine Injection Generics Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.5% (5 mg/mL), 1% (10 mg/mL), 2% (20 mg/mL)
Reference Brands: Xylocaine®, Lidocaine Injection USP(US & EU)
Category:
Anaesthetics
Lidocaine Injection is a fast-acting local anesthetic available in 0.5%, 1%, and 2% strengths, with or without epinephrine, used for anesthesia and arrhythmia management. Approved in the US and EU for hospital and clinical use.
Lidocaine Injection Generics is available in Injection
and strengths such as 0.5% (5 mg/mL), 1% (10 mg/mL), 2% (20 mg/mL).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lidocaine Injection Generics is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lidocaine Injection Generics can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lidocaine Injection is a fast-acting local anesthetic and Class 1B antiarrhythmic widely used in surgical, dental, and emergency care settings. Available in 0.5%, 1%, and 2% strengths, with or without epinephrine, it provides effective pain control for infiltration, nerve blocks, epidurals, and IV use. Lidocaine Injection is FDA-approved in the US and CE-marked in the EU, making it a trusted solution in hospitals and clinics. Offered in preservative-free and multi-dose formats, it meets varied clinical needs. This high-demand injectable presents excellent B2B opportunities for distributors, hospitals, tenders, and licensing partners in regulated pharmaceutical markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing